What is Eledon Pharmaceuticals Inc?
operates as a clinical stage biotechnology company.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 150.34M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.